Ranbaxy Laboratories, the domestic pharma major, has got the Good Manufacturing Practice certificate from the Ministry of Health and Labour Welfare - Japan for its non-sterile drug plant at Dewas in India.
The approval has been granted for a period of five years and will cover all products that are currently manufactured at this site and that will be filed in the future for Japan.